Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Whats new CLL KC

    Launch of Chronic Lymphocytic Leukaemia (CLL)
    Knowledge Centre

    The new CLL Knowledge Centre contains useful resources for healthcare professionals
    treating this condition. There are three key areas: ‘Disease awareness’ (epidemiology,
    pathophysiology, diagnosis and treatment), ‘Events’ (upcoming meetings and congresses)
    and ‘Resources’ (links to useful sites and organisations).

  • ,AIKN CDI May Update

    Anti-Infectives Knowledge Network (AIKN) CDI Updates

    The Anti-Infectives Knowledge Network – Clostridium difficile infection (AIKN-CDI) has
    recently been updated with new content including presentation slides from EBMT and
    ECCMID 2015, a gut microflora animation unveiled at the Astellas stand during
    ECCMID 2015, recent articles added to the ‘CDI perspectives’ section and the
    opportunity to participate in a second round consensus questionnaire for the
    ​largest ever clinician consensus report.

    May 2015 MYC/15/0020/EUb

  • ,Whats New CSU

    Launch of Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre

    A new Chronic Spontaneous Urticaria (CSU) Knowledge Centre has
    launched on epgonline.org to raise awareness and improve early diagnosis
    of the condition. Healthcare professionals will have free access to a
    disease overview, recent symposia highlights, a video channel and useful resources.

  • ,Whats new Psoriasis Knowledge centre

    Launch of Psoriasis Knowledge Centre

    A new Psoriasis Knowledge Centre has launched on epgonline.org
    to provide dermatologists, family medicine physicians and other healthcare
    professionals with free access to relevant information on psoriasis including
    pathophysiology, comorbidities, signs and symptoms, diagnosis and more.

  • ,What's New ECCMID IFI

    Anti-Infectives Knowledge Network (AIKN) IFI Updates

    The AIKN-IFI has been updated with four presentations from the Astellas-sponsored
    symposium at the 25th European Congress of Clinical Microbiology and Infectious
    Diseases (ECCMID) 2015
    . The congress took place on 25–28 April in Copenhagen,
    Denmark. Visit the congresses section of this resource to view and download the slides
    free of charge.

    May 2015 MYC/15/0040/EUb

Latest News

rVIII-SingleChain (recombinant factor VIII single-chain) filed with FDA for haemophilia A- CSL Behring


The FDA has accepted for review a Biologics License Application for rVIII-SingleChain (recombinant factor VIII single-chain), from CSL Behring, for the treatment of haemophilia A. In the pivotal clinical trial, rVIII-SingleChain met all primary ...

CHMP recommends EU label expansion of Synflorix vaccine for pneumococcal disease- Glaxo Smith Kline


The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for the expansion of the European label of Synflorix vaccine, from Glaxo Smith Kline. The updated label now includes effectiveness data ...

Phase III trial of AMG 412 (epratuzumab) fails in Systemic Lupus Erythematosus- UCB


UCB announced that the two EMBODY Phase III clinical studies for AMG 412 (epratuzumab) in Systemic Lupus Erythematosus (SLE) did not meet their primary clinical efficacy endpoints in either dose in both studies. Treatment response in patients who ...

Mallinckrodt sells contrast media and delivery systems business to Guerbet for $270 million.


Mallinckrodt plc announced that it has entered into a definitive agreement under which it will sell its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million. For the first six ...

Teva buys Allergan generics business


Teva Pharmaceutical Industries Ltd. announced that it has signed a definitive agreement with Allergan plc to acquire Allergan Generics in a transaction valued at $40.5 billion. Upon closing, Allergan will receive $33.75 billion in cash and shares of ...

EU Commission extends indication of Kuvan (sapropterin dihydrochloride) to include children with phenylketonuria (PKU)-Merck KGaA


Merck KGaA/Merck Serono has announced that the European Commission (EC) has authorized a change to the European marketing authorization for its product Kuvan (sapropterin dihydrochloride), to allow its use in children with phenylketonuria (PKU) below ...

Genzyme acquires Caprelsa (vandetanib) from AstraZeneca.


AstraZeneca announced that it has entered into a definitive agreement with Genzyme to divest Caprelsa (vandetanib), a rare disease medicine. Caprelsa was granted Orphan Drug Designation by the US FDA in 2005 and is currently available in 28 ...

Recent Updates


Clinical Guidelines

European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke

Anaemia management in people with chronic kidney disease

Lower urinary tract symptoms: The management of lower urinary tract symptoms in men

Suspected cancer: recognition and referral

Medical Journals

Tiotropium and salmeterol in COPD patients at risk of exacerbations: a post hoc analysis from POET-COPD.

Functional Impairments Mediate Association Between Clinical Fracture Risk and Type 2 Diabetes Mellitus in Older Women.

Treating patients with metastatic castration-resistant prostate cancer: a comprehensive review of available therapies.

The Effect of Bisphosphonates on Bone Mineral Density in Metastatic Prostate Cancer Patients Who Are Treated with Anti-Androgen Drugs and Radiotherapy

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors